Australian Broker Call *Extra* Edition – May 28, 2026

Array
(
    [0] => Array
        (
            [0] => ((AEL))
            [1] => ((BPT))
            [2] => ((ASK))
            [3] => ((ABG))
            [4] => ((ASK))
            [5] => ((ABG))
            [6] => ((AUE))
            [7] => ((BML))
            [8] => ((SFR))
            [9] => ((CU6))
            [10] => ((CY5))
            [11] => ((ERD))
            [12] => ((ERD))
            [13] => ((EXP))
            [14] => ((FLT))
            [15] => ((FPH))
            [16] => ((HUM))
            [17] => ((CCP))
            [18] => ((KCN))
            [19] => ((KGN))
            [20] => ((PEB))
            [21] => ((SLC))
            [22] => ((SSM))
            [23] => ((TRE))
            [24] => ((VGL))
            [25] => ((WC8))
            [26] => ((WZR))
        )

    [1] => Array
        (
            [0] => AEL
            [1] => BPT
            [2] => ASK
            [3] => ABG
            [4] => ASK
            [5] => ABG
            [6] => AUE
            [7] => BML
            [8] => SFR
            [9] => CU6
            [10] => CY5
            [11] => ERD
            [12] => ERD
            [13] => EXP
            [14] => FLT
            [15] => FPH
            [16] => HUM
            [17] => CCP
            [18] => KCN
            [19] => KGN
            [20] => PEB
            [21] => SLC
            [22] => SSM
            [23] => TRE
            [24] => VGL
            [25] => WC8
            [26] => WZR
        )

)

This story features AMPLITUDE ENERGY LIMITED, and other companies.
For more info SHARE ANALYSIS: AEL
The company is included in ASX300 and ALL-ORDS

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.

In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.

One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.

Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.

Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.

The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.

The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.

COMPANIES DISCUSSED IN THIS ISSUE

Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)

AEL   ASK (2)   AUE   BML   CU6   CY5   ERD (2)   EXP   FLT   FPH   HUM   KCN   KGN   PEB   SLC   SSM   TRE   VGL   WC8   WZR  

AEL    AMPLITUDE ENERGY LIMITED

Crude Oil – Overnight Price: $1.75

Canaccord Genuity rates ((AEL)) as Speculative Buy (1) –

Canaccord Genuity retains a Speculative Buy rating for Amplitude Energy with its target price decreased to $2.75 from $2.84 following the strategic asset acquisition of a 50% operated interest in the Artisan gas discovery from Beach Energy ((BPT)).

The asset position sits 17km from existing pipeline infrastructure, allowing a low-cost subsea tie-in that de-risks the final investment decision for the broader project, commentary suggests.

Initial technical evaluations confirm the low-inert gas composition is compatible with the Athena processing facility and offers potential blending opportunities to optimise higher impurity fields.

The upfront consideration of -$58.3m plus capped production royalties remains fully funded by a balance sheet showing $345m in undrawn credit lines.

Near-term operational catalyst milestones focus on upcoming exploration results from the Juliet-1 well alongside finalised development completions on the subsea tree, the broker notes.

This report was published on May 26, 2026.

Target price is $2.75 Current Price is $1.75 Difference: $0.995
If AEL meets the Canaccord Genuity target it will return approximately 57% (excluding dividends, fees and charges).
Current consensus price target is $2.90, suggesting upside of 64.8%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is 20.0, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 8.8.

Forecast for FY27:

Current consensus EPS estimate is 23.9, implying annual growth of 19.5%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 7.4.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ASK    ABACUS STORAGE KING

REITs – Overnight Price: $1.41

Moelis rates ((ASK)) as Buy (1) –

Moelis maintains a Buy rating for Abacus Storage King with its target price increased to $1.63 from $1.59 following an update on the management internalisation process.

The real estate investment trust agreed to acquire the management rights from Abacus Group ((ABG)) for an upfront price of $19m alongside $5m for net assets.

The structural simplification represents the final step of destapling and allows direct oversight of the portfolio, which is expected to deliver a 6% accretion to funds from operations.

Management reiterated FY26 distribution guidance of 6.2c despite ongoing peer discounting activity and a weaker macroeconomic environment in New Zealand, commentary highlights.

This report was published on May 27, 2026.

Target price is $1.63 Current Price is $1.41 Difference: $0.225
If ASK meets the Moelis target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $1.58, suggesting upside of 12.3%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Moelis forecasts a full year FY26 dividend of 6.20 cents and EPS of 6.30 cents.
At the last closing share price the estimated dividend yield is 4.41%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 22.30.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 6.8, implying annual growth of -69.1%.
Current consensus DPS estimate is 6.2, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 20.7.

Forecast for FY27:

Moelis forecasts a full year FY27 dividend of 6.30 cents and EPS of 6.60 cents.
At the last closing share price the estimated dividend yield is 4.48%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.29.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 7.1, implying annual growth of 4.4%.
Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 4.5%.
Current consensus EPS estimate suggests the PER is 19.9.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

Shaw and Partners rates ((ASK)) as Buy (1) –

Shaw and Partners maintains a Buy rating for Abacus Storage King with its target price decreased to $1.60 from $1.65 following a corporate restructuring update.

The real estate investment trust will internalise management and operate independently from Abacus Storage Group ((ABG)), rebranding as Storage King Group from the end of June.

The transaction is expected to deliver cost savings equivalent to 6% accretion to funds from operations on a pro-forma FY26 basis.

Despite the strategic efficiencies, underlying earnings forecasts are downgraded by up to -4.5% to reflect highly competitive trading conditions and a weakened New Zealand economic environment.

The revised valuation incorporates these near-term margin pressures alongside softer capitalisation rates stemming from elevated interest rates, the broker notes.

This report was published on May 27, 2026.

Target price is $1.60 Current Price is $1.41 Difference: $0.195
If ASK meets the Shaw and Partners target it will return approximately 14% (excluding dividends, fees and charges).
Current consensus price target is $1.58, suggesting upside of 12.3%(ex-dividends)
The company’s fiscal year ends in June.

Forecast for FY26:

Shaw and Partners forecasts a full year FY26 dividend of 6.20 cents and EPS of 6.20 cents.
At the last closing share price the estimated dividend yield is 4.41%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 22.66.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 6.8, implying annual growth of -69.1%.
Current consensus DPS estimate is 6.2, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 20.7.

Forecast for FY27:

Shaw and Partners forecasts a full year FY27 dividend of 6.40 cents and EPS of 6.40 cents.
At the last closing share price the estimated dividend yield is 4.56%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.95.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 7.1, implying annual growth of 4.4%.
Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 4.5%.
Current consensus EPS estimate suggests the PER is 19.9.

Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

AUE    AURUM RESOURCES LIMITED

Gold & Silver – Overnight Price: $0.61

Canaccord Genuity rates ((AUE)) as Speculative Buy (1) –

Canaccord Genuity maintains a Speculative Buy rating for Aurum Resources with a $1.55 target price following the receipt of major environmental approvals for the Boundiali gold project in Cote d’Ivoire.

Commentary suggests the issuance of three assessment certificates across the mining licence application areas represents a key de-risking milestone and clears the pathway for final regulatory review.

A recent 24% upgrade to indicated resources at the asset to 1.70Moz of contained gold is expected to underpin a pre-feasibility study slated for release this quarter.

The broker estimates the deposit could support an operation delivering 160,000 to 175,000 ounces annually over a ten-year mine life at an all-in sustaining cost around US$1,600/oz.

Aggressive resource growth drilling continues with 16 company-owned diamond rigs operating on site, supported by a $61m cash balance at the end of March 2026.

This report was published on May 25, 2026.

Target price is $1.55 Current Price is $0.61 Difference: $0.94
If AUE meets the Canaccord Genuity target it will return approximately 154% (excluding dividends, fees and charges).

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

BML    BOAB METALS LIMITED

Mining – Overnight Price: $0.40

Shaw and Partners rates ((BML)) as Buy (1) –

Shaw and Partners retains a Buy rating for Boab Metals with a $1.70 target price following a site visit to the Sorby Hills silver-lead project in Western Australia.

Early site works are complete, including the site-access road, while camp construction and ground works for the process plant remain underway.

Commercial production is on track for the second half of FY27, utilising the disassembled Degrussa processing plant acquired from Sandfire Resources ((SFR)).

The project is fully funded through recent capital raises and debt packages, positioning the company to generate substantial annual cash flow at current elevated silver spot prices, commentary suggests.

Upcoming near-term catalysts include the release of an optimised project delivery plan and ongoing resource-to-reserve drilling to extend the existing mine life.

This report was published on May 26, 2026.

Target price is $1.70 Current Price is $0.40 Difference: $1.3
If BML meets the Shaw and Partners target it will return approximately 325% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 57.14.

Forecast for FY27:

Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 1.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 23.53.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CU6    CLARITY PHARMACEUTICALS LIMITED

Medical Equipment & Devices – Overnight Price: $2.61

Canaccord Genuity rates ((CU6)) as Buy (1) –

Canaccord Genuity maintains a Buy rating for Clarity Pharmaceuticals with a $8.41 target price following recent clinical data and sector updates.

Commentary highlights the 64Cu-SAR-bisPSMA imaging franchise demonstrates clinical differentiation via superior lesion sensitivity at low prostate-specific antigen levels, significantly optimising salvage management pathways.

This high-fidelity staging capability is expected to resonate with major pharmaceutical partners seeking to de-risk patient selection for early-stage hormone-sensitive prostate cancer trials.

Furthermore, the therapeutic candidate 67Cu-SAR-bisPSMA offers a distinct operational advantage in micrometastatic niches through combined beta and high-energy Auger electron emissions.

Potential large-scale consolidation within the radiopharmacy sector remains neutral to the corporate investment thesis due to the unique technical advantages of the underlying technology platform, the report concludes.

This report was published on May 26, 2026.

Target price is $8.41 Current Price is $2.61 Difference: $5.8
If CU6 meets the Canaccord Genuity target it will return approximately 222% (excluding dividends, fees and charges).

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

CY5    CYGNUS METALS LIMITED

Gold & Silver – Overnight Price: $0.13

Canaccord Genuity rates ((CY5)) as Speculative Buy (1) –

Canaccord Genuity retains a Speculative Buy rating for Cygnus Metals with a $0.35 target price following strong high-grade infill drill results from the Golden Eye deposit within the Chibougamau copper-gold project in Quebec.

Commentary highlights recent assay highlights including 8.4m at 16.3g/t gold equivalent from 135m and 3.6m at 15.7g/t gold equivalent from 218m demonstrate excellent continuity within the shallow gold-rich system.

The 15-hole winter drilling campaign specifically targeted the conversion of inferred resources into the higher-confidence indicated category, ahead of a mineral resource update expected in the September quarter of 2026.

Regional drilling at the nearby Gwillim gold target is underway, with co-funding from joint venture partner Alamos Gold (Canada).

A scoping study slated for mid 2026 will build upon previous technical assessments and incorporate updated commodity and cost assumptions, the report concludes.

This report was published on May 25, 2026.

Target price is $0.35 Current Price is $0.13 Difference: $0.22
If CY5 meets the Canaccord Genuity target it will return approximately 169% (excluding dividends, fees and charges).

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

ERD    EROAD LIMITED

Transportation & Logistics – Overnight Price: $0.79

Moelis rates ((ERD)) as Buy (1) –

Moelis maintains a Buy rating for Eroad with a $2.04 target price following management’s operational review of regional strategies.

Three major factors weigh heavily on the near-term financial performance, led by an estimated -$13m higher amortisation charge following accelerated rates for capitalised development costs.

Higher software platform operational costs and a 16% revenue rebasing in North America due to a large customer non-renewal further pressure earnings guidance.

The regional operating model structural pivot is supported by steady execution in Australia and New Zealand, where the completed 4G upgrade and high-value devices help protect margins.

While aligning corporate overhead costs to the reduced scale will require a multi-year transformation timeline, the broker views regional separation as supportive of longer-term sum-of-the-parts valuations.

This report was published on May 26, 2026.

Target price is $2.04 Current Price is $0.79 Difference: $1.255
If ERD meets the Moelis target it will return approximately 160% (excluding dividends, fees and charges).
The company’s fiscal year ends in March.

Forecast for FY26:

Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 10.46 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 7.51.

Forecast for FY27:

Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 14.73 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 5.33.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

Shaw and Partners rates ((ERD)) as Buy (1) –

Shaw and Partners reiterates its Buy rating for Eroad with its target price decreased to $1.10 from $2.50 following the release of FY26 financial results.

Total revenue grew by 0.4% to $195.2m during the period, driven by strong enterprise additions in Australia and single-digit growth in New Zealand.

Commentary explains normalised earnings before interest and tax fell below previous expectations to $2.9m due to lower asset creation and elevated cash costs in North America.

Operating cash conversion remained resilient, helping deliver positive normalised free cash flow of $14.4m to support the ongoing business transformation.

The revised valuation reflects lower long-term cash flows and a more conservative weighting applied to upcoming electronic road user charging opportunities.

This report was published on May 26, 2026.

Target price is $1.10 Current Price is $0.79 Difference: $0.315
If ERD meets the Shaw and Partners target it will return approximately 40% (excluding dividends, fees and charges).
The company’s fiscal year ends in March.

Forecast for FY26:

Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 9.24 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 8.50.

Forecast for FY27:

Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 8.45 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 9.29.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

EXP    EXPERIENCE CO LIMITED

Travel, Leisure & Tourism – Overnight Price: $0.09

Canaccord Genuity rates ((EXP)) as Buy (1) –

Canaccord Genuity maintains a Buy rating for Experience Co with its target price decreased to $0.15 from $0.16 following a ten-month trading update.

Unaudited year-to-date earnings of $17.4m fell slightly below expectations due to weak April trading volumes within the Skydive Australia division alongside emerging price sensitivity at Reef Unlimited.

The preceding March quarter demonstrated operational resilience against protected industrial action, severe weather events, and broader macroeconomic inflationary pressures.

Management continues restructuring the domestic portfolio by placing the Melbourne drop zone into care and maintenance while permanently closing the Yarra Valley site.

Forward underlying earnings estimates are downgraded by up to -4% to reflect these localised volume headwinds, while the broker expects free cash flow will return to comfortably positive territory in FY27.

This report was published on May 27, 2026.

Target price is $0.15 Current Price is $0.09 Difference: $0.063
If EXP meets the Canaccord Genuity target it will return approximately 72% (excluding dividends, fees and charges).

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

FLT    FLIGHT CENTRE TRAVEL GROUP LIMITED

Travel, Leisure & Tourism – Overnight Price: $9.88

Canaccord Genuity rates ((FLT)) as Buy (1) –

Canaccord Genuity maintains a Buy rating for Flight Centre Travel with a $14.60 target price following an investor day presentation outlining portfolio growth opportunities.

Management showcased long-term strategic initiatives across various business units but stopped short of formally reiterating short-term earnings guidance amidst ongoing geopolitical disruptions, the broker reports.

The conflict in Iran poses a clear downside risk to near-term trading conditions, leading the broker to forecast FY26 profit before tax of $305.2m, falling below the bottom end of the official guidance range.

Broadening scale and deep industry relationships present significant operational upside over time, though some portfolio segments may continue facing localised pressures.

Meaningful share price re-rating is anticipated once Middle Eastern air and seaways reopen and the geopolitical conflict reaches a sustainable resolution.

This report was published on May 27, 2026.

Target price is $14.60 Current Price is $9.88 Difference: $4.72
If FLT meets the Canaccord Genuity target it will return approximately 48% (excluding dividends, fees and charges).
Current consensus price target is $15.23, suggesting upside of 54.1%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is 97.8, implying annual growth of 97.1%.
Current consensus DPS estimate is 45.4, implying a prospective dividend yield of 4.6%.
Current consensus EPS estimate suggests the PER is 10.1.

Forecast for FY27:

Current consensus EPS estimate is 115.4, implying annual growth of 18.0%.
Current consensus DPS estimate is 52.5, implying a prospective dividend yield of 5.3%.
Current consensus EPS estimate suggests the PER is 8.6.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

FPH    FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

Medical Equipment & Devices – Overnight Price: $31.29

Canaccord Genuity rates ((FPH)) as Buy (1) –

Canaccord Genuity maintains a Buy rating for Fisher & Paykel Healthcare with its target price decreased to $36.50 from $37.50 following the release of the FY26 financial results.

Management provided FY27 earnings guidance targeting net profit after tax between NZ$500m and NZ$550m on revenues approaching NZ$2.57bn.

The midpoint of these projections implies flat hardware sales alongside double-digit growth rates across both hospital consumables and sleep apnea masks, commentary explains.

Rising component costs and elevated freight rates stemming from the Middle East conflict create a 70 basis point gross margin headwind, partially offset by favorable tariff conditions.

Modest downward revisions to terminal growth assumptions drive the valuation adjustment, yet underlying clinical excellence continues supporting the premium market position of the biomedical device manufacturer, the broker concludes.

This report was published on May 27, 2026.

Target price is $36.50 Current Price is $31.29 Difference: $5.21
If FPH meets the Canaccord Genuity target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is N/A

Forecast for FY27:

Current consensus EPS estimate is 75.3, implying annual growth of N/A.
Current consensus DPS estimate is 48.0, implying a prospective dividend yield of 1.5%.
Current consensus EPS estimate suggests the PER is 41.6.

Forecast for FY28:

Current consensus EPS estimate is 87.0, implying annual growth of 15.5%.
Current consensus DPS estimate is 54.3, implying a prospective dividend yield of 1.7%.
Current consensus EPS estimate suggests the PER is 36.0.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

HUM    HUMM GROUP LIMITED

Business & Consumer Credit – Overnight Price: $0.60

Shaw and Partners rates ((HUM)) as Buy (1) –

Shaw and Partners maintains a Buy rating for Humm Group with a $0.85 target price following the release of the March quarter trading update.

The broker opines the financial results show strong credit quality and resilient consumer card margins helping offset macroeconomic headwinds within the large commercial division.

Flexicommercial volumes fell -4% relative to the prior corresponding period as competitive pressures and rising interest rates compressed net interest margins by -50 basis points.

Adjusted earnings estimates are reduced -11% to -19% across the forecast period to account for these margin pressures and one-off corporate transaction costs.

A takeover proposal from Credit Corp ((CCP)) remains under active consideration while further due diligence is conducted.

This report was published on May 26, 2026.

Target price is $0.85 Current Price is $0.60 Difference: $0.245
If HUM meets the Shaw and Partners target it will return approximately 40% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Shaw and Partners forecasts a full year FY26 dividend of 2.70 cents and EPS of 6.10 cents.
At the last closing share price the estimated dividend yield is 4.46%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 9.92.

Forecast for FY27:

Shaw and Partners forecasts a full year FY27 dividend of 3.20 cents and EPS of 10.30 cents.
At the last closing share price the estimated dividend yield is 5.29%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 5.87.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

KCN    KINGSGATE CONSOLIDATED LIMITED

Gold & Silver – Overnight Price: $6.55

Canaccord Genuity rates ((KCN)) as Buy (1) –

Canaccord Genuity maintains a Buy rating for Kingsgate Consolidated with a $10.30 target price following the acquisition of third-party royalty and water rights for the Nueva Esperanza silver project in Chile.

The transaction involves a -US$21.6m consideration comprising -US$15.6m in upfront cash alongside contingent milestone payments tied to commercial production or potential corporate agreements.

Commentary explains removing these legacy royalty obligations and securing long-term water access significantly de-risks the asset while clearing the pathway for a potential corporate spin-out.

Workstreams have commenced to assess lower-cost heap leach processing options to accelerate development timelines for the 82Moz silver equivalent resource base.

Minor revisions to unit cost inputs and modelled mine grades at the Chatree operation leave broader valuation metrics unchanged, with the broker noting the current share price attributes minimal value to the wider South American portfolio.

This report was published on May 27, 2026.

Target price is $10.30 Current Price is $6.55 Difference: $3.75
If KCN meets the Canaccord Genuity target it will return approximately 57% (excluding dividends, fees and charges).

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

KGN    KOGAN.COM LIMITED

Retailing – Overnight Price: $4.13

Canaccord Genuity rates ((KGN)) as Buy (1) –

Canaccord Genuity maintains a Buy rating for Kogan.com with a $7.50 target price following a strong ten-month business update.

Group gross sales increased 13% over the period, driven by an 18% surge in the core platform which offset a -14% decline across the New Zealand-based Mighty Ape division.

Gross profit margins expanded to a record 41%, while disciplined operating expenditure supported adjusted earnings of $38m at an 8.6% margin, commentary highlights, sitting at the top end of management guidance.

The report concludes the integration of the core marketplace strategy at Mighty Ape has successfully removed underperforming product categories, placing the subsidiary on track to exit FY26 at an earnings breakeven run rate.

Adjusted earnings estimates are revised 5% and 2% higher for FY26 and FY27 respectively, with the broker noting the retailer’s resilient market positioning amidst broader consumer headwinds.

This report was published on May 27, 2026.

Target price is $7.50 Current Price is $4.13 Difference: $3.37
If KGN meets the Canaccord Genuity target it will return approximately 82% (excluding dividends, fees and charges).

Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

PEB    PACIFIC EDGE LIMITED

Medical Equipment & Devices – Overnight Price: $0.21

Jarden rates ((PEB)) as Neutral (3) –

Jarden maintains a Neutral rating for Pacific Edge with its target price increased to NZ$0.20 from NZ$0.16 following an in-line FY26 financial result.

Global clinical test volumes declined by -16% relative to the prior corresponding period due to a Medicare non-coverage determination and downsized sales resources within the United States.

Operational metrics reflect growing commercial volume contributions from both the core payer mix and the targeted Triage platform alongside ongoing development of the high-fidelity Triage Plus asset.

Management targets an aggregate FY27 monthly cash burn ceiling of -NZ$2.5m, implying an annualised revenue milestone run rate exceeding NZ$17m based on current underlying fixed operating cost structures.

The upgraded valuation is driven by improved confidence surrounding long-term commercial test adoption forecasts alongside a reduced discount rate following steady progress on the draft local coverage determination, the broker notes.

This report was published on May 26, 2026.

Current Price is $0.21. Target price not assessed.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

SLC    SUPERLOOP LIMITED

Telecommunication – Overnight Price: $3.69

Canaccord Genuity rates ((SLC)) as Buy (1) –

Canaccord Genuity maintains a Buy rating for Superloop with a $3.74 target price ahead of an upcoming investor day presentation.

Management is expected to outline new three-year financial ambitions and provide greater clarity regarding unit economics within the Smart Communities division.

Near-term operating performance remains strong across both the consumer and wholesale segments, positioning the business well against current FY26 earnings guidance between $112m and $120m, the broker suggests.

Elevated returns on marketing investment could prompt sustained promotional spending through the remainder of the period to maximise subscriber momentum.

While incoming national broadband network wholesale cost increases will test the broader sector, the broker anticipates the telecommunications provider can successfully balance competitive retail pricing with ongoing gross margin expansion.

This report was published on May 27, 2026.

Target price is $3.74 Current Price is $3.69 Difference: $0.05
If SLC meets the Canaccord Genuity target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $3.51, suggesting downside of -4.9%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is 7.2, implying annual growth of 2900.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 51.2.

Forecast for FY27:

Current consensus EPS estimate is 10.2, implying annual growth of 41.7%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 36.2.

Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

SSM    SERVICE STREAM LIMITED

Industrial Sector Contractors & Engineers – Overnight Price: $2.37

Canaccord Genuity rates ((SSM)) as Buy (1) –

Canaccord Genuity maintains a Buy rating for Service Stream with its target price increased to $2.70 from $2.60 following an agreement to acquire Queensland-based high-voltage specialist RIE Group.

The strategic bolt-on transaction involves an upfront consideration of $6.5m alongside a $1.5m performance-contingent earn-out structured across FY27.

The acquired entity delivers technical electrical and instrumentation shutdown services across oil, gas, and renewable sectors, complementing the existing utilities asset management portfolio.

Operational cost synergies and immediate scaling opportunities across an expanded blue chip industrial infrastructure network prompt upward revisions to forward revenue and margin forecasts.

The acquisition remains fully funded via existing balance sheet liquidity, which reflects an underlying net cash position of $87.6m, the broker notes.

This report was published on May 26, 2026.

Target price is $2.70 Current Price is $2.37 Difference: $0.33
If SSM meets the Canaccord Genuity target it will return approximately 14% (excluding dividends, fees and charges).
Current consensus price target is $2.73, suggesting upside of 15.0%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is 11.7, implying annual growth of 21.1%.
Current consensus DPS estimate is 6.2, implying a prospective dividend yield of 2.6%.
Current consensus EPS estimate suggests the PER is 20.3.

Forecast for FY27:

Current consensus EPS estimate is 13.9, implying annual growth of 18.8%.
Current consensus DPS estimate is 6.8, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 17.1.

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

TRE    TOUBANI RESOURCES LIMITED REGISTERED

Gold & Silver – Overnight Price: $0.40

Canaccord Genuity rates ((TRE)) as Speculative Buy (1) –

Canaccord Genuity maintains a Speculative Buy rating for Toubani Resources with a $1.85 target price following the successful final investment decision for the Kobada gold project.

Rapid progression into the construction phase positions the asset on an 18-month development timeline targeting initial gold production by the third quarter of 2027.

Execution milestones continue advancing with commitments now covering 50% of the US$216m forecast capital expenditure, supported by a recently secured US$73.3m senior debt facility from Coris Bank International.

Combined with a US$80m gold stream and existing cash reserves, the developer remains comfortably funded to complete the build without requiring additional equity, the report points out.

Local security disruptions in Mali have not impacted site operations, leaving the broker confident the current market valuation overcompensates for regional jurisdiction risk.

This report was published on May 27, 2026.

Target price is $1.85 Current Price is $0.40 Difference: $1.455
If TRE meets the Canaccord Genuity target it will return approximately 368% (excluding dividends, fees and charges).

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

VGL    VISTA GROUP INTERNATIONAL LIMITED

Software & Services – Overnight Price: $2.15

Canaccord Genuity rates ((VGL)) as Buy (1) –

Canaccord Genuity maintains a Buy rating for Vista International with a $4.00 target price following a major contract win in the Latin American cinema market.

The enterprise software provider signed a five-year agreement with Cinemex to transition 312 sites across Mexico and the United States onto the base Vista Cloud platform throughout 2026.

Winning back this major operator alongside the recent Cinepolis rollout elevates global enterprise market share to 49% and provides the first material uplift to overall site counts since FY19.

Management maintained FY26 revenue guidance between $176m and $182m with operating margin targets of 18% to 20%, which the broker views as increasingly conservative given the new customer addition.

Sustained momentum in migrating major exhibitors to higher-value cloud solutions underwrites medium-term free cash flow projections and justifies ongoing investments in transition capacity, the broker notes.

This report was published on May 27, 2026.

Target price is $4.00 Current Price is $2.15 Difference: $1.85
If VGL meets the Canaccord Genuity target it will return approximately 86% (excluding dividends, fees and charges).
Current consensus price target is $3.10, suggesting upside of 44.2%(ex-dividends)

Forecast for FY26:

Current consensus EPS estimate is 4.6, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 46.7.

Forecast for FY27:

Current consensus EPS estimate is 5.2, implying annual growth of 13.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 41.3.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

WC8    WILDCAT RESOURCES LIMITED

New Battery Elements – Overnight Price: $0.56

Canaccord Genuity rates ((WC8)) as Speculative Buy (1) –

Canaccord Genuity maintains a Speculative Buy rating for Wildcat Resources with its target price increased to $1.30 from $1.10 following a site visit to the Tabba Tabba lithium project.

A pending definitive feasibility study is reportedly 70% complete and targets a September quarter release, incorporating project scope refinements such as accelerated underground development and a staged plant expansion.

These operational adjustments expand modelled production to 656,000 tonnes per annum from 2033 while delivering an estimated 10% improvement in all-in sustaining costs.

Management expects to submit construction applications this month to maintain a schedule targeting site development in 2027 and initial production in 2028.

Strong interest from potential strategic partners and commercial financiers provides the broker confidence the asset will be comfortably funded through the current cycle.

This report was published on May 27, 2026.

Target price is $1.30 Current Price is $0.56 Difference: $0.735
If WC8 meets the Canaccord Genuity target it will return approximately 130% (excluding dividends, fees and charges).

Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

WZR    WISR LIMITED

Business & Consumer Credit – Overnight Price: $0.02

Shaw and Partners rates ((WZR)) as Buy (1) –

Shaw and Partners maintains a Buy rating for Wisr with a 6.7c target price following the execution of its largest asset-backed securitisation transaction to date.

The upsized $354m transaction frees up substantial warehouse capacity for growth while releasing $7.5m of cash back into the business.

Commentary explains portfolio scaling from $1.0bn in the March quarter of FY26 toward a target of $2.0bn by the end of FY28 will be supported by this expanded funding capability without requiring additional equity.

Stable risk-adjusted net interest margins between 3.75% and 3.80% are anticipated through FY27 as improved credit quality and secured vehicle loan mix offset rising underlying rates.

Flat headcount across the period underpins robust operating leverage, the broker concludes, helping drive normalised net profit after tax from break-even in FY26 to $23m by FY28.

This report was published on May 26, 2026.

Target price is $0.07 Current Price is $0.02 Difference: $0.046
If WZR meets the Shaw and Partners target it will return approximately 219% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.

Forecast for FY26:

Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.00 cents.

Forecast for FY27:

Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.50 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 4.20.

All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.

This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.

Click to view our Glossary of Financial Terms